Drug Shortage Report for TEVA-TOBRAMYCIN

Last updated on 2020-02-07 History
Report ID 103593
Drug Identification Number 02389622
Brand name TEVA-TOBRAMYCIN
Common or Proper name TOBRAMYCIN INH SLN 60MG/ML 5ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 60MG
Dosage form(s) SOLUTION
Route of administration INHALATION
Packaging size 56
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15
Estimated end date 2020-02-29
Actual end date 2020-02-06
Shortage status Resolved
Updated date 2020-02-07
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-17 English Compare
v2 2020-01-17 French Compare
v3 2020-02-07 English Compare
v4 2020-02-07 French Compare